DC12482 |
PTC299
Featured
|
PTC299 (PTC-299) is a novel potent inhibitor of dihydroorotate dehydrogenase (DHODH), inhibits hypoxia-induced VEGFA protein production in HeLa cells with IC50 of 1.64 nM. |
|
DC21543 |
PTC725 |
PTC725 is a potent, selective, and orally bioavailable inhibitor of HCV NS4B, inhibits HCV 1b (Con1) replicons with EC50 of 1.7 nM. |
|
DC20592 |
Pterosin B |
Pterosin B is a potent and specific SIK3 signaling inhibitor that suppresses SIK3 downstream cascades by up-regulating the phosphorylation levels in the SIK3 C-terminal regulatory domain. |
|
DC20516 |
PTGR2-IN-22 |
PTGR2-IN-22 is a potent PTGR2 ligand that inhibits 15-keto-PGE2 reductase activity with IC50 of 0.55 uM in HEK293T cells. |
|
DC10333 |
PTP1B-IN-2
Featured
|
PTP1B-IN-2 is a novel protein tyrosine phosphatase-1B (PTP1B) inhibitor. |
|
DC20517 |
PTP1B-IN-5b |
PTP1B-IN-5b is a potent protein tyrosine phosphatase PTP1B inhibitor with IC50 of 5.25 uM. |
|
DC20518 |
PTUPB |
PTUPB is a novel dual acting COX-2/sEH inhibitor with IC50 of 1.26 uM/0.9 nM,does not inhibits COX-1 (IC50>100 uM). |
|
DC8129 |
PTZ-343
Featured
|
PTZ-343 is a phenothiazine derivative with chemical name: sodium 3-(10H-phenothiazin-10-yl)propane-1-sulfonate. |
|
DC23354 |
PU-139 |
PU-139 is a potent, unselective HAT (Histone acetyltransferase) inhibitor that blocks the HATs Gcn5, p300/CBP-associated factor (PCAF), CREB protein (CBP) and p300. |
|
DC23363 |
PU-141 |
PU-141 is a potent, selective CBP/p300 inhibitor that inhibits SK-N-SH cell growth with GI50 of 0.48 uM. |
|
DC9919 |
Pulchinenoside A |
Pulchinenoside A is a natural triterpenoid saponin that enhances synaptic plasticity in the adult mouse hippocampus and facilitates spatial memory in adult mice. |
|
DC9911 |
Pulsatilla saponin D(SB365) |
Pulsatilla saponin D(SB365) isolated from the root of Pulsatilla koreana, has exhibited potential beneficial effects as a chemopreventive agent for critical health conditions including cancer. |
|
DC23274 |
Purfalcamine
Featured
|
Purfalcamine is a potent, specific inhibitor of Plaasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) with IC50 of 17 nM. |
|
DCZ-287 |
Protopine |
purity >98%,Standard References |
|
DCZ-284 |
Allosecurinine |
Allosecurinine (Phyllochrysine) is a Securinega alkaloid isolated from Phyllanthus glaucus . |
|
DCZ-291 |
isorhapontigenin |
purity >98%,Standard References |
|
DCZ-292 |
TECTOCHRYSIN |
purity >98%,Standard References |
|
DCZ-290 |
Isobavachin |
purity >98%,Standard References |
|
DCZ-286 |
8-GERANOPSORALEN |
purity >98%,Standard References |
|
DCZ-289 |
songorine |
purity >98%,Standard References |
|
DC7255 |
Purmorphamine
Featured
|
Purmorphamine, which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo with IC50 of ~ 1.5 μM and also is an inducer of osteoblast differentiation with EC50 of 1 μM. |
|
DC8558 |
Puromycin aminonucleoside
Featured
|
Puromycin Aminonucleoside (3'-Amino-3'-deoxy-N6,N6-dimethyladenosine) is the aminonucleoside portion of the antibiotic puromycin. |
|
DC10169 |
Puromycin
Featured
|
Puromycin is an aminoglycoside antibiotic isolated from the bacterium Streptomyces alboniger. It is a protein synthesis inhibitor. |
|
DC8075 |
Purvalanol A(NG 60)
Featured
|
Purvalanol A is a potent, cell-permeable cyclin-dependent protein kinase (cdk) inhibitor. |
|
DC7256 |
Purvalanol B(NG-95)
Featured
|
Purvalanol B(NG-95) is a cyclin-dependent kinase inhibitor with IC50 values of 6, 6, 9, > 10,000, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively. |
|
DC23344 |
PVZB-1194 |
PVZB-1194 is a bis(hetero)aryl derivative that inhibits kinesin spindle protein (KSP) ATPase witn IC50 of 0.12 uM. |
|
DC26129 |
PWT143 (ME-401)
Featured
|
PWT143 (ME-401), is an orally bioavailable inhibitor of the delta isoform of phosphatidylinositide 3-kinase (PI3K), with potential antineoplastic activity. |
|
DC23657 |
PWZ-029 |
PWZ-029 is a potent, subtype-selective partial inverse agonist of α5 GABAA receptors with Ki of 30 nM, demonstrates memory enhancing effects in vivo. |
|
DC20222 |
Px-104 |
Px-104(Px-102) is a farnesoid X receptor (FXR) agonist potentially for the treatment of non-alcoholic fatty liver disease. |
|
DC7992 |
PX 12
Featured
|
PX-12(IV-2) is an irreversible inhibitor of Thioredoxin-1(Trx-1) currently in clinical development as an antitumor agent; IC50=7 uM in Hela, MTT assay, 72 h. |
|